169 related articles for article (PubMed ID: 38532715)
41. Studies on the conformational changes in the bacterial cell wall biosynthetic enzyme UDP-N-acetylglucosamine enolpyruvyltransferase (MurA).
Schönbrunn E; Svergun DI; Amrhein N; Koch MH
Eur J Biochem; 1998 Apr; 253(2):406-12. PubMed ID: 9654090
[TBL] [Abstract][Full Text] [Related]
42. Development of a whole-cell assay for peptidoglycan biosynthesis inhibitors.
Barbosa MD; Yang G; Fang J; Kurilla MG; Pompliano DL
Antimicrob Agents Chemother; 2002 Apr; 46(4):943-6. PubMed ID: 11897573
[TBL] [Abstract][Full Text] [Related]
43. Determination of the pKa value of C115 in MurA (UDP-N-acetylglucosamine enolpyruvyltransferase) from Enterobacter cloacae.
Krekel F; Samland AK; Macheroux P; Amrhein N; Evans JN
Biochemistry; 2000 Oct; 39(41):12671-7. PubMed ID: 11027147
[TBL] [Abstract][Full Text] [Related]
44. Avenaciolides: potential MurA-targeted inhibitors against peptidoglycan biosynthesis in methicillin-resistant Staphylococcus aureus (MRSA).
Chang CM; Chern J; Chen MY; Huang KF; Chen CH; Yang YL; Wu SH
J Am Chem Soc; 2015 Jan; 137(1):267-75. PubMed ID: 25521652
[TBL] [Abstract][Full Text] [Related]
45. The unusual binding mode of cnicin to the antibacterial target enzyme MurA revealed by X-ray crystallography.
Steinbach A; Scheidig AJ; Klein CD
J Med Chem; 2008 Aug; 51(16):5143-7. PubMed ID: 18672863
[TBL] [Abstract][Full Text] [Related]
46. Characterization of mycobacterial UDP-N-acetylglucosamine enolpyruvyle transferase (MurA).
Xu L; Wu D; Liu L; Zheng Q; Song Y; Ye L; Sha S; Kang J; Xin Y; Ma Y
Res Microbiol; 2014; 165(2):91-101. PubMed ID: 24463011
[TBL] [Abstract][Full Text] [Related]
47. Potential Inhibitors Targeting
Raina D; Kumar C; Kumar V; Khan IA; Saran S
Indian J Microbiol; 2022 Mar; 62(1):11-22. PubMed ID: 35068599
[TBL] [Abstract][Full Text] [Related]
48. Identification and Biochemical Characterization of Pyrrolidinediones as Novel Inhibitors of the Bacterial Enzyme MurA.
Fathalla RK; Fröhner W; Bader CD; Fischer PD; Dahlem C; Chatterjee D; Mathea S; Kiemer AK; Arthanari H; Müller R; Abdel-Halim M; Ducho C; Engel M
J Med Chem; 2022 Nov; 65(21):14740-14763. PubMed ID: 36269107
[TBL] [Abstract][Full Text] [Related]
49. Identification of novel MurA inhibitors using
Tiwari H; Raina D; Gupta M; Barik MR; Khan IA; Khan F; Nargotra A
J Biomol Struct Dyn; 2023 Feb; 41(2):457-468. PubMed ID: 34866550
[TBL] [Abstract][Full Text] [Related]
50. Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of
Kurnia D; Hutabarat GS; Windaryanti D; Herlina T; Herdiyati Y; Satari MH
Drug Des Devel Ther; 2020; 14():2977-2985. PubMed ID: 32801638
[TBL] [Abstract][Full Text] [Related]
51. Evidence that the reaction of the UDP-N-acetylglucosamine 1-carboxyvinyltransferase proceeds through the O-phosphothioketal of pyruvic acid bound to Cys115 of the enzyme.
Wanke C; Amrhein N
Eur J Biochem; 1993 Dec; 218(3):861-70. PubMed ID: 8281938
[TBL] [Abstract][Full Text] [Related]
52. Identification of novel irreversible inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Haemophilus influenzae.
Han SG; Lee WK; Jin BS; Lee KI; Lee HH; Yu YG
J Microbiol Biotechnol; 2013 Mar; 23(3):329-34. PubMed ID: 23462005
[TBL] [Abstract][Full Text] [Related]
53. Characterization and inhibition study of MurA enzyme by capillary electrophoresis.
Dai HJ; Parker CN; Bao JJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):123-32. PubMed ID: 11820287
[TBL] [Abstract][Full Text] [Related]
54. Identification of a novel fosfomycin-resistant UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from a soil metagenome.
Cheng G; Hu Y; Lu N; Li J; Wang Z; Chen Q; Zhu B
Biotechnol Lett; 2013 Feb; 35(2):273-8. PubMed ID: 23143172
[TBL] [Abstract][Full Text] [Related]
55. Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ).
Miller K; Dunsmore CJ; Leeds JA; Patching SG; Sachdeva M; Blake KL; Stubbings WJ; Simmons KJ; Henderson PJ; De Los Angeles J; Fishwick CW; Chopra I
J Antimicrob Chemother; 2010 Dec; 65(12):2566-73. PubMed ID: 20861142
[TBL] [Abstract][Full Text] [Related]
56. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
57. Crystal structure of UDP-N-acetylglucosamine enolpyruvyltransferase, the target of the antibiotic fosfomycin.
Schönbrunn E; Sack S; Eschenburg S; Perrakis A; Krekel F; Amrhein N; Mandelkow E
Structure; 1996 Sep; 4(9):1065-75. PubMed ID: 8805592
[TBL] [Abstract][Full Text] [Related]
58. A protein antibiotic in the phage Qbeta virion: diversity in lysis targets.
Bernhardt TG; Wang IN; Struck DK; Young R
Science; 2001 Jun; 292(5525):2326-9. PubMed ID: 11423662
[TBL] [Abstract][Full Text] [Related]
59. The
Borisova M; Gisin J; Mayer C
mBio; 2017 Mar; 8(2):. PubMed ID: 28351914
[TBL] [Abstract][Full Text] [Related]
60. Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of
Kumar P; Saumya KU; Giri R
J Biomol Struct Dyn; 2020 Oct; 38(17):4997-5013. PubMed ID: 31755364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
